Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 15;210(6):737-754.
doi: 10.1164/rccm.202312-2249SO.

Asthma Inception: Epidemiologic Risk Factors and Natural History Across the Life Course

Erik Melén  1 , Heather J Zar  2 , Valerie Siroux  3 , Dominic Shaw  4 , Sejal Saglani  5 , Gerard H Koppelman  6 , Tina Hartert  7 , James E Gern  8 , Benjamin Gaston  9 , Andrew Bush  5 , Joe Zein  10
Affiliations
Review

Asthma Inception: Epidemiologic Risk Factors and Natural History Across the Life Course

Erik Melén et al. Am J Respir Crit Care Med. .

Abstract

Asthma is a descriptive label for an obstructive inflammatory disease in the lower airways manifesting with symptoms including breathlessness, cough, difficulty in breathing, and wheezing. From a clinician's point of view, asthma symptoms can commence at any age, although most patients with asthma-regardless of their age of onset-seem to have had some form of airway problems during childhood. Asthma inception and related pathophysiologic processes are therefore very likely to occur early in life, further evidenced by recent lung physiologic and mechanistic research. Herein, we present state-of-the-art updates on the role of genetics and epigenetics, early viral and bacterial infections, immune response, and pathophysiology, as well as lifestyle and environmental exposures, in asthma across the life course. We conclude that early environmental insults in genetically vulnerable individuals inducing abnormal, pre-asthmatic airway responses are key events in asthma inception, and we highlight disease heterogeneity across ages and the potential shortsightedness of treating all patients with asthma using the same treatments. Although there are no interventions that, at present, can modify long-term outcomes, a precision-medicine approach should be implemented to optimize treatment and tailor follow-up for all patients with asthma.

Keywords: allergy; child; epidemiology; genetics; risk factor.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Porsbjerg C, Melen E, Lehtimaki L, Shaw D. Asthma. Lancet . 2023;401:858–873. - PubMed
    1. Gaillard EA, Kuehni CE, Turner S, Goutaki M, Holden KA, de Jong CCM, et al. European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years. Eur Respir J . 2021;58:2004173. - PubMed
    1. El-Husseini ZW, Gosens R, Dekker F, Koppelman GH. The genetics of asthma and the promise of genomics-guided drug target discovery. Lancet Respir Med . 2020;8:1045–1056. - PubMed
    1. Hernandez-Pacheco N, Kere M, Melen E. Gene-environment interactions in childhood asthma revisited; expanding the interaction concept. Pediatr Allergy Immunol . 2022;33:e13780. - PMC - PubMed
    1. Vicedo-Cabrera AM, Melen E, Forastiere F, Gehring U, Katsouyanni K, Yorgancioglu A, et al. Climate change and respiratory health: a European Respiratory Society position statement. Eur Respir J . 2023;62:2201960. - PubMed